The panel’s decisions followed hours of debate about a slew of recent studies suggesting the Pfizer vaccine becomes less effective at protecting against coronavirus infection over time. Key BackgroundThe Biden administration was aiming to begin the mass distribution of Covid-19 booster shots in the U.S. next week. Leaders at the World Health Organization, meanwhile, have repeatedly warned prioritizing booster shots for wealthy nations over inoculations in countries with low vaccination rates could lead to the emergence of more dangerous variants. Further Reading“Scientific Evidence Doesn’t Back Booster Covid Shots, Researchers Warn — Even For The Delta Variant” (Forbes)“As the F.D.A. vaccine panel considers Pfizer boosters, experts present conflicting data on the shots” (The New York Times)Full coverage and live updates on the Coronavirus

Source: Forbes September 17, 2021 14:55 UTC